首页 > 最新文献

中国医师杂志最新文献

英文 中文
The predictive value of serum EOS% and FeNO in stable phase of COPD for the therapeutic effect of glucocorticoids COPD稳定期血清EOS%和FeNO对糖皮质激素治疗效果的预测价值
Q4 Medicine Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.ISSN.1008-1372.2020.02.022
Yanhua Mao, Weijun Cao
Objective To investigate the predictive value of peripheral blood eosinophil percentage (EOS%) and exhaled nitric oxide (FeNO) on the efficacy of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) at stable stage. Methods A total of 78 patients with stable COPD during the outpatient clinic from January 2017 to December 2018 were enrolled. EOS%, FeNO, and pulmonary function indicators [forced vital capacity(FVC), forced expiratory volume in 1 sec (FEV1), peak expiratory flow (PEF)] were measured after ICS-free elution. The questionnaire was used to assess the severity of the symptoms. The above indicators were reviewed after 4 weeks of ICS treatment. According to the improvement of pulmonary function and chronic obstructive pulmonary disease assessment (CAT) improvement , the patients were divided into effective and ineffective groups. Pearson correlation analysis and receiver operating characteristic (ROC) curve were used to analyze the predictive value of EOS% and FeNO for ICS. Results After ICS treatment, EOS% and FeNO were lower, FVC, FEV1, and PEF were higher than before, and CAT score was lower than before (P 0.05). The FeNO level in the effective group was higher than that in the ineffective group before and after ICS treatment, with statistically significant difference (P 0.05); the area under the ROC curve for EOS% prediction of ICS efficacy before treatment was 0.531 (P>0.05), with critical value 3.13%, the sensitivity 57.1% and specificity 52.4%, respectively. The area under the ROC curve of FeNO for ICS treatment before treatment was 0.628 (P<0.05), with critical value 30.00%, sensitivity and specificity (64.6% and 91.0%) respectively. Conclusions For patients with stable COPD, EOS% and FeNO levels are positively correlated with the improvement of FEV1 after ICS treatment. Both of them can predict the efficacy of ICS to a certain extent, and FeNO has higher predictive value than EOS%, which can be applied to clinical practice. Key words: Pulmonary disease, chronic obstructive; Eosinophils; Fractional exhaled nitric oxide; Inhaled glucocorticoid
目的探讨外周血嗜酸性粒细胞百分比(EOS%)和呼出一氧化氮(FeNO)对稳定期慢性阻塞性肺疾病(COPD)患者吸入糖皮质激素(ICS)疗效的预测价值。方法选取2017年1月至2018年12月门诊就诊的稳定期COPD患者78例。无ics洗脱后测定EOS%、FeNO和肺功能指标[用力肺活量(FVC)、1秒用力呼气量(FEV1)、呼气峰流量(PEF)]。问卷用于评估症状的严重程度。ICS治疗4周后复查上述指标。根据肺功能改善情况和慢性阻塞性肺疾病(CAT)改善情况,将患者分为有效组和无效组。采用Pearson相关分析和受试者工作特征(ROC)曲线分析EOS%和FeNO对ICS的预测价值。结果ICS治疗后患者EOS%、FeNO均低于治疗前,FVC、FEV1、PEF均高于治疗前,CAT评分低于治疗前(P < 0.05)。ICS治疗前后,有效组FeNO水平高于无效组,差异有统计学意义(P < 0.05);EOS%预测治疗前ICS疗效的ROC曲线下面积为0.531 (P>0.05),临界值为3.13%,敏感性为57.1%,特异性为52.4%。ICS治疗前FeNO ROC曲线下面积为0.628 (P<0.05),临界值为30.00%,敏感性为64.6%,特异性为91.0%。结论稳定期COPD患者的EOS%和FeNO水平与ICS治疗后FEV1的改善呈正相关。两者均能在一定程度上预测ICS的疗效,其中FeNO的预测值高于EOS%,可应用于临床实践。关键词:肺部疾病;慢性阻塞性肺疾病;嗜酸性粒细胞;分式呼出一氧化氮;吸入糖皮质激素
{"title":"The predictive value of serum EOS% and FeNO in stable phase of COPD for the therapeutic effect of glucocorticoids","authors":"Yanhua Mao, Weijun Cao","doi":"10.3760/CMA.J.ISSN.1008-1372.2020.02.022","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2020.02.022","url":null,"abstract":"Objective \u0000To investigate the predictive value of peripheral blood eosinophil percentage (EOS%) and exhaled nitric oxide (FeNO) on the efficacy of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) at stable stage. \u0000 \u0000 \u0000Methods \u0000A total of 78 patients with stable COPD during the outpatient clinic from January 2017 to December 2018 were enrolled. EOS%, FeNO, and pulmonary function indicators [forced vital capacity(FVC), forced expiratory volume in 1 sec (FEV1), peak expiratory flow (PEF)] were measured after ICS-free elution. The questionnaire was used to assess the severity of the symptoms. The above indicators were reviewed after 4 weeks of ICS treatment. According to the improvement of pulmonary function and chronic obstructive pulmonary disease assessment (CAT) improvement , the patients were divided into effective and ineffective groups. Pearson correlation analysis and receiver operating characteristic (ROC) curve were used to analyze the predictive value of EOS% and FeNO for ICS. \u0000 \u0000 \u0000Results \u0000After ICS treatment, EOS% and FeNO were lower, FVC, FEV1, and PEF were higher than before, and CAT score was lower than before (P 0.05). The FeNO level in the effective group was higher than that in the ineffective group before and after ICS treatment, with statistically significant difference (P 0.05); the area under the ROC curve for EOS% prediction of ICS efficacy before treatment was 0.531 (P>0.05), with critical value 3.13%, the sensitivity 57.1% and specificity 52.4%, respectively. The area under the ROC curve of FeNO for ICS treatment before treatment was 0.628 (P<0.05), with critical value 30.00%, sensitivity and specificity (64.6% and 91.0%) respectively. \u0000 \u0000 \u0000Conclusions \u0000For patients with stable COPD, EOS% and FeNO levels are positively correlated with the improvement of FEV1 after ICS treatment. Both of them can predict the efficacy of ICS to a certain extent, and FeNO has higher predictive value than EOS%, which can be applied to clinical practice. \u0000 \u0000 \u0000Key words: \u0000Pulmonary disease, chronic obstructive; Eosinophils; Fractional exhaled nitric oxide; Inhaled glucocorticoid","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74282802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of irbesartan combined with hemodialysis on renal hemodynamics in patients with renal proteinuria 厄贝沙坦联合血液透析对肾性蛋白尿患者肾脏血流动力学的影响
Q4 Medicine Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.ISSN.1008-1372.2020.02.018
Jie Shen, B. Dai
Objective To explore the effects of irbesartan combined with hemodialysis on renal function, inflammatory factors and renal hemodynamics in patients with renal proteinuria. Methods A total of 106 patients with renal proteinuria who underwent hemodialysis in Changzheng Hospital Affiliated to Naval Medical University from May 2016 to May 2018 were selected for the study and were divided into observation group and control group according to the random number table method. The two groups were given hemodialysis, and observation group was given irbesartan on this basis. Kidney-related examination indexes [24 h urine protein quantitation, 24 h urine volume, serum creatinine (Scr), urea nitrogen (BUN)], inflammatory factors [C-reactive protein (CRP), interleukin-8 (IL-8), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1)], bilateral renal interlobar artery resistance index (RI), hemorheology (whole blood viscosity, low-shear viscosity, high-shear viscosity, erythrocyte aggregation index) were observed in the two groups before and after treatment. Results After 3 months of treatment, the levels of urine protein quantitation, serum Scr, BUN, CRP, IL-8, ICAM-1 and MCP-1 in the two groups were lower than those before treatment, and the levels in observation group were lower than those in control group (P<0.05); the 24h urine volume was more than that before treatment, and the level in observation group was more than that in control group (P<0.05). The RI values of bilateral kidney in the two groups were lower than those before treatment, and the value in observation group was lower than that in control group (P<0.05). The whole blood viscosity, low-shear viscosity, high-shear viscosity and erythrocyte aggregation index in the two groups were lower than those before treatment, and the indexes in observation group were lower than those in control group (P<0.05). Conclusions Addition of irbesartan in patients with renal proteinuria treated by hemodialysis can effectively improve renal function, reduce inflammation and blood viscosity, and improve renal hemodynamics, and promote the disease outcomes. Key words: Irbesartan; Hemodialysis; Renal proteinyria; Hemodynamics
目的探讨厄贝沙坦联合血液透析对肾性蛋白尿患者肾功能、炎症因子及肾血流动力学的影响。方法选择2016年5月至2018年5月在海军医科大学附属长征医院接受血液透析治疗的肾性蛋白尿患者106例,按随机数字表法分为观察组和对照组。两组患者均给予血液透析治疗,观察组患者在此基础上给予厄贝沙坦治疗。肾脏相关检查指标[24小时尿蛋白定量、24小时尿量、血清肌酐(Scr)、尿素氮(BUN)]、炎症因子[c反应蛋白(CRP)、白细胞介素-8 (IL-8)、细胞间粘附分子-1 (ICAM-1)、单核细胞趋化蛋白-1 (MCP-1)]、双侧肾叶间动脉阻力指数(RI)、血液流变学(全血粘度、低剪切粘度、高剪切粘度、观察两组患者治疗前后红细胞聚集指数(红细胞聚集指数)。结果治疗3个月后,两组患者尿蛋白定量、血清Scr、BUN、CRP、IL-8、ICAM-1、MCP-1水平均低于同组治疗前,且观察组低于对照组(P<0.05);24h尿量显著高于治疗前,且观察组显著高于对照组(P<0.05)。两组患者双侧肾脏RI值均低于治疗前,且观察组低于对照组(P<0.05)。两组患者全血粘度、低剪切粘度、高剪切粘度及红细胞聚集指数均低于治疗前,且观察组患者各项指标均低于对照组(P<0.05)。结论血液透析治疗肾性蛋白尿患者加用厄贝沙坦可有效改善肾功能,降低炎症和血液黏度,改善肾脏血流动力学,促进疾病转归。关键词:厄贝沙坦;血液透析;肾proteinyria;血液动力学
{"title":"Effect of irbesartan combined with hemodialysis on renal hemodynamics in patients with renal proteinuria","authors":"Jie Shen, B. Dai","doi":"10.3760/CMA.J.ISSN.1008-1372.2020.02.018","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2020.02.018","url":null,"abstract":"Objective \u0000To explore the effects of irbesartan combined with hemodialysis on renal function, inflammatory factors and renal hemodynamics in patients with renal proteinuria. \u0000 \u0000 \u0000Methods \u0000A total of 106 patients with renal proteinuria who underwent hemodialysis in Changzheng Hospital Affiliated to Naval Medical University from May 2016 to May 2018 were selected for the study and were divided into observation group and control group according to the random number table method. The two groups were given hemodialysis, and observation group was given irbesartan on this basis. Kidney-related examination indexes [24 h urine protein quantitation, 24 h urine volume, serum creatinine (Scr), urea nitrogen (BUN)], inflammatory factors [C-reactive protein (CRP), interleukin-8 (IL-8), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1)], bilateral renal interlobar artery resistance index (RI), hemorheology (whole blood viscosity, low-shear viscosity, high-shear viscosity, erythrocyte aggregation index) were observed in the two groups before and after treatment. \u0000 \u0000 \u0000Results \u0000After 3 months of treatment, the levels of urine protein quantitation, serum Scr, BUN, CRP, IL-8, ICAM-1 and MCP-1 in the two groups were lower than those before treatment, and the levels in observation group were lower than those in control group (P<0.05); the 24h urine volume was more than that before treatment, and the level in observation group was more than that in control group (P<0.05). The RI values of bilateral kidney in the two groups were lower than those before treatment, and the value in observation group was lower than that in control group (P<0.05). The whole blood viscosity, low-shear viscosity, high-shear viscosity and erythrocyte aggregation index in the two groups were lower than those before treatment, and the indexes in observation group were lower than those in control group (P<0.05). \u0000 \u0000 \u0000Conclusions \u0000Addition of irbesartan in patients with renal proteinuria treated by hemodialysis can effectively improve renal function, reduce inflammation and blood viscosity, and improve renal hemodynamics, and promote the disease outcomes. \u0000 \u0000 \u0000Key words: \u0000Irbesartan; Hemodialysis; Renal proteinyria; Hemodynamics","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77910537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking the controversy between laparotomy and laparoscopy in cervical cancer surgery 宫颈癌手术开腹与腹腔镜手术争议的再思考
Q4 Medicine Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.ISSN.1008-1372.2020.02.007
Qing Liu, Kaijiang Liu
Since 2018, the controversy between laparotomy and minimally invasive surgery for cervical cancer has been paid attention widespread, In addition, we should analyze the other problems in cervical cancer surgery objectively and comprehensively. Laparoscopic surgery has been rapidly popularized in China due to its advantages over the past 10 years. However, there are still many points in the treatment of cervical cancer in China, such as not paying attention to the concept of tumor-free, not strictly grasping the indications for surgery, inadequate surgical scope, and lack of oncologist training, etc, which needs we pay more attention. In order to obtain the best therapeutic effect, we not only pay attention to the discuss of laparotomy and minimally invasive of the cervical cancer, but should also pay attention to the nature of tumor treatment. Key words: Uterine cervical neoplasms; Laparotomy; Laparoscopy
2018年以来,宫颈癌开腹手术与微创手术之争引起广泛关注,此外,我们还应客观、全面地分析宫颈癌手术中存在的其他问题。近10年来,腹腔镜手术因其优势在中国迅速普及。但是,目前国内对宫颈癌的治疗还存在着不重视无瘤概念、不严格把握手术指征、手术范围不够广、肿瘤医师培训不足等诸多问题,需要我们多加重视。为了获得最佳的治疗效果,我们不仅要重视对宫颈癌的开腹手术和微创治疗的讨论,还应注意肿瘤治疗的性质。关键词:子宫颈肿瘤;剖腹手术;腹腔镜检查
{"title":"Rethinking the controversy between laparotomy and laparoscopy in cervical cancer surgery","authors":"Qing Liu, Kaijiang Liu","doi":"10.3760/CMA.J.ISSN.1008-1372.2020.02.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2020.02.007","url":null,"abstract":"Since 2018, the controversy between laparotomy and minimally invasive surgery for cervical cancer has been paid attention widespread, In addition, we should analyze the other problems in cervical cancer surgery objectively and comprehensively. Laparoscopic surgery has been rapidly popularized in China due to its advantages over the past 10 years. However, there are still many points in the treatment of cervical cancer in China, such as not paying attention to the concept of tumor-free, not strictly grasping the indications for surgery, inadequate surgical scope, and lack of oncologist training, etc, which needs we pay more attention. In order to obtain the best therapeutic effect, we not only pay attention to the discuss of laparotomy and minimally invasive of the cervical cancer, but should also pay attention to the nature of tumor treatment. \u0000 \u0000Key words: \u0000Uterine cervical neoplasms; Laparotomy; Laparoscopy","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87169943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of colposcopy screening independently for cervical lesions in basic hospitals 阴道镜在基层医院宫颈病变独立筛查中的价值
Q4 Medicine Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.ISSN.1008-1372.2020.02.005
Gong Yuan, Huimin Zhang, Fei Gou, Jun Wang, Caihong Liu, Donglin Li
Objective To evaluate the value of colposcopy screening independently for cervical lesions in basic hospitals. Methods A retrospective cohort study of 574 patients who both underwent colposcopy and had pathologic results in our department. The consistency, authenticity and predictability of colposcopy and pathological results, the relevant factors affecting the accuracy of colposcopy diagnosis, and the analysis of unsatisfactory colposcopy results were analyzed. Results Agreement between colposcopic diagnosis and cervical pathology was 50.57%, and Kappa value of consistency was 0.358 (P<0.01). Agreement within one grade was 91.38 % (Kappa value was 0.871, P<0.01). The sensitivity of colposcopy in diagnosing of low-grade squamous intraepithelial lesion (LSIL) and above was high (96.91%), while the specificity was 52.60% (81/154); False positive rate was 47.40%, and false negative rate was 3.09%. The sensitivity of colposcopy in diagnosing of high-grade squamous intraepithelial lesion (HSIL) and above was 81.82% (153/187), and the specificity in diagnosing of LSIL and below was 90.68% (146/161); False positive rate was 9.3%, and false negative rate was 18.2%. The stage of cervical cancer and skills of colposcopist would be factors that influence the accuracy of colposcopy screening in HSIL and above (P<0.01). Average age in unsatisfactory colposcopy was (52±9)y, which was significantly different from satisfactory colposcopy cases (P<0.01). The proportion of early cervical lesions in patients with unsatisfactory colposcopy HSIL or above was high. Conclusions The complete coincidence rate between colposcopy and pathological diagnosis is limited, but the consistency within one grade is good; the stage of cervical lesions and the experience of examiners are the factors related to the accuracy of colposcopy in diagnosing HSIL and above lesions; Unsatisfactory colposcopy cases can be further combined with cytology and HPV examination for shunt and treatment. Key words: Colposcopy; Uterine cervical diseases; Sensitivity and specificity
目的探讨阴道镜独立筛查在基层医院宫颈病变中的应用价值。方法对我科574例经阴道镜检查并有病理结果的患者进行回顾性队列研究。分析阴道镜检查结果与病理结果的一致性、真实性和可预测性,影响阴道镜诊断准确性的相关因素,以及对阴道镜检查结果不满意情况的分析。结果阴道镜诊断与宫颈病理吻合率为50.57%,一致性Kappa值为0.358 (P<0.01)。1级以内的一致性为91.38% (Kappa值为0.871,P<0.01)。阴道镜对低级别鳞状上皮内病变(LSIL)及以上的诊断敏感性高(96.91%),特异性为52.60% (81/154);假阳性率47.40%,假阴性率3.09%。阴道镜诊断高级别鳞状上皮内病变(HSIL)及以上的敏感性为81.82%(153/187),诊断低级别鳞状上皮内病变(LSIL)及以下的特异性为90.68% (146/161);假阳性率为9.3%,假阴性率为18.2%。宫颈癌分期和阴道镜医师技能是影响HSIL及以上患者阴道镜筛查准确性的因素(P<0.01)。阴道镜检查不满意组的平均年龄为(52±9)岁,与阴道镜检查满意组差异有统计学意义(P<0.01)。阴道镜检查不满意的HSIL及以上患者早期宫颈病变的比例较高。结论阴道镜检查与病理诊断完全符合率有限,但一级内一致性较好;宫颈病变分期和检查人员经验是影响阴道镜诊断HSIL及以上病变准确性的因素;阴道镜检查不满意的病例可进一步结合细胞学和HPV检查进行分流和治疗。关键词:阴道镜检查;子宫颈疾病;敏感性和特异性
{"title":"Value of colposcopy screening independently for cervical lesions in basic hospitals","authors":"Gong Yuan, Huimin Zhang, Fei Gou, Jun Wang, Caihong Liu, Donglin Li","doi":"10.3760/CMA.J.ISSN.1008-1372.2020.02.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2020.02.005","url":null,"abstract":"Objective To evaluate the value of colposcopy screening independently for cervical lesions in basic hospitals. Methods A retrospective cohort study of 574 patients who both underwent colposcopy and had pathologic results in our department. The consistency, authenticity and predictability of colposcopy and pathological results, the relevant factors affecting the accuracy of colposcopy diagnosis, and the analysis of unsatisfactory colposcopy results were analyzed. Results Agreement between colposcopic diagnosis and cervical pathology was 50.57%, and Kappa value of consistency was 0.358 (P<0.01). Agreement within one grade was 91.38 % (Kappa value was 0.871, P<0.01). The sensitivity of colposcopy in diagnosing of low-grade squamous intraepithelial lesion (LSIL) and above was high (96.91%), while the specificity was 52.60% (81/154); False positive rate was 47.40%, and false negative rate was 3.09%. The sensitivity of colposcopy in diagnosing of high-grade squamous intraepithelial lesion (HSIL) and above was 81.82% (153/187), and the specificity in diagnosing of LSIL and below was 90.68% (146/161); False positive rate was 9.3%, and false negative rate was 18.2%. The stage of cervical cancer and skills of colposcopist would be factors that influence the accuracy of colposcopy screening in HSIL and above (P<0.01). Average age in unsatisfactory colposcopy was (52±9)y, which was significantly different from satisfactory colposcopy cases (P<0.01). The proportion of early cervical lesions in patients with unsatisfactory colposcopy HSIL or above was high. Conclusions The complete coincidence rate between colposcopy and pathological diagnosis is limited, but the consistency within one grade is good; the stage of cervical lesions and the experience of examiners are the factors related to the accuracy of colposcopy in diagnosing HSIL and above lesions; Unsatisfactory colposcopy cases can be further combined with cytology and HPV examination for shunt and treatment. Key words: Colposcopy; Uterine cervical diseases; Sensitivity and specificity","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85338596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of harmine on osteosarcoma cell proliferation and apoptosis by down regulating COX-2 expression 毒芹碱通过下调COX-2表达对骨肉瘤细胞增殖和凋亡的影响
Q4 Medicine Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.ISSN.1008-1372.2020.02.011
Zhongchen Li, Cuhang Chen, Jia-Zheng Jin
Objective To investigate the inhibitory effect of harmine on osteosarcoma cell proliferation and apoptosis by down regulating cyclooxygenase-2 (COX-2) expression. Methods Human osteosarcoma cell line U2OS was cultured in vitro and randomly divided into control group, study group 1, study group 2 and study group 3. The cells were cultured in 0, 5 μmol/L, 10 μmol/L and 20 μmol/L concentration of harmine for 48 hours. Cell counting kit-8 (CCK-8) method and flow cytometry were used to detect cell viability and apoptosis. The expression level of COX-2, proliferation and apoptosis related proteins and mRNA were detected by Western blot and real-time quantitative polymerase chain reaction (RT-qPCR), respectively. Results After cultured with different concentrations of harmine for 12, 24 hours and 48 hours, the cell viability of the three study groups were significantly lower than that of the control group (P<0.05), while that of the study groups 2 and 3 were significantly lower than that of the study group 1 (P<0.05). The apoptosis rate of the three study groups were significantly higher than that of the control group (P<0.05), while that of the two groups were significantly higher than that of the study group 1 (P<0.05). After 48 hours of culture, the levels of COX-2, cyclin D1, proliferating cell nuclear antigen (PCNA), B-cell lymphoma-2 (Bcl-2) protein and mRNA expression in study group 2 were significantly lower than those in control group, while the expression levels of cleaved caspase-3 and BCL2-Associated X (Bax) in study group 2 were significantly higher than those in control group (P<0.05) . Conclusions Harmine can inhibit the proliferation and promote the apoptosis of osteosarcoma cells by inhibiting the expression of COX-2 and regulating the expression of cell cycle and apoptosis related protein. Key words: Cyclooxygenase 2; Harmine; Osteosarcoma; Cell line, tumor
目的探讨鼠碱通过下调环氧合酶-2 (COX-2)表达对骨肉瘤细胞增殖和凋亡的抑制作用。方法体外培养人骨肉瘤细胞系U2OS,随机分为对照组、研究1组、研究2组和研究3组。细胞分别在浓度为0、5、10、20 μmol/L的毒碱中培养48 h。采用细胞计数试剂盒-8 (CCK-8)法和流式细胞术检测细胞活力和凋亡情况。采用Western blot和real-time quantitative polymerase chain reaction (RT-qPCR)分别检测COX-2、增殖与凋亡相关蛋白和mRNA的表达水平。结果不同浓度鼠碱培养12、24、48 h后,3个研究组的细胞活力均显著低于对照组(P<0.05),研究组2、3的细胞活力均显著低于研究组1 (P<0.05)。三个研究组的细胞凋亡率均显著高于对照组(P<0.05),且两组细胞凋亡率均显著高于研究1组(P<0.05)。培养48h后,研究2组细胞COX-2、cyclin D1、增殖细胞核抗原(PCNA)、b细胞淋巴瘤-2 (Bcl-2)蛋白水平及mRNA表达量均显著低于对照组,而cleaved caspase-3、BCL2-Associated X (Bax)表达量显著高于对照组(P<0.05)。结论鼠碱通过抑制COX-2的表达,调节细胞周期及凋亡相关蛋白的表达,抑制骨肉瘤细胞增殖,促进骨肉瘤细胞凋亡。关键词:环加氧酶2;骆驼蓬碱;骨肉瘤;细胞系、肿瘤
{"title":"Effect of harmine on osteosarcoma cell proliferation and apoptosis by down regulating COX-2 expression","authors":"Zhongchen Li, Cuhang Chen, Jia-Zheng Jin","doi":"10.3760/CMA.J.ISSN.1008-1372.2020.02.011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2020.02.011","url":null,"abstract":"Objective \u0000To investigate the inhibitory effect of harmine on osteosarcoma cell proliferation and apoptosis by down regulating cyclooxygenase-2 (COX-2) expression. \u0000 \u0000 \u0000Methods \u0000Human osteosarcoma cell line U2OS was cultured in vitro and randomly divided into control group, study group 1, study group 2 and study group 3. The cells were cultured in 0, 5 μmol/L, 10 μmol/L and 20 μmol/L concentration of harmine for 48 hours. Cell counting kit-8 (CCK-8) method and flow cytometry were used to detect cell viability and apoptosis. The expression level of COX-2, proliferation and apoptosis related proteins and mRNA were detected by Western blot and real-time quantitative polymerase chain reaction (RT-qPCR), respectively. \u0000 \u0000 \u0000Results \u0000After cultured with different concentrations of harmine for 12, 24 hours and 48 hours, the cell viability of the three study groups were significantly lower than that of the control group (P<0.05), while that of the study groups 2 and 3 were significantly lower than that of the study group 1 (P<0.05). The apoptosis rate of the three study groups were significantly higher than that of the control group (P<0.05), while that of the two groups were significantly higher than that of the study group 1 (P<0.05). After 48 hours of culture, the levels of COX-2, cyclin D1, proliferating cell nuclear antigen (PCNA), B-cell lymphoma-2 (Bcl-2) protein and mRNA expression in study group 2 were significantly lower than those in control group, while the expression levels of cleaved caspase-3 and BCL2-Associated X (Bax) in study group 2 were significantly higher than those in control group (P<0.05) . \u0000 \u0000 \u0000Conclusions \u0000Harmine can inhibit the proliferation and promote the apoptosis of osteosarcoma cells by inhibiting the expression of COX-2 and regulating the expression of cell cycle and apoptosis related protein. \u0000 \u0000 \u0000Key words: \u0000Cyclooxygenase 2; Harmine; Osteosarcoma; Cell line, tumor","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81655801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression and its clinicopathological significance of Survivin, MSH2 and MSH6 in colorectal cancer Survivin、MSH2和MSH6在结直肠癌中的表达及其临床病理意义
Q4 Medicine Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.ISSN.1008-1372.2020.02.016
Juhua Chen, Yili Wang, Hongwei H Zhang
Objective To analyze the changes of Survivin, MSH6 and MSH2 expression in colorectal cancer and explore their relationship with clinical and pathological parameters. Methods 197 cases of colorectal adenocarcinoma and 20 cases of inflammatory intestinal mucosa were detected by immunohistochemistry with Survivin, MSH6 and MSH2, and the correlation between Survivin, MSH6 and MSH2 expression was analyzed. Results In the control group of 20 cases with inflammatory non-tumor intestinal mucosa, the positive expression rate of MSH2, MSH6, Survivin were 95%, 95%, 10%, respectively. While the positive expression rate of MSH2, MSH6, Survivin were 88.3%, 74.1% and 84.3% in 197 cases of colorectal cancer. Survivin positive expression rate in colorectal cancer group was significantly higher than that in inflammatory control group (P 0.05). MSH2 expression was correlated with tumor size and lymph node metastasis (P 0.05). MSH6 expression was related to gender and lymph node metastasis (P 0.05). Colorectal cancer tissues showed positive correlation between MSH6 and MSH2 (r=0.326, P<0.01), positive correlation between MSH2 and Survivin positive expression (r=0.277, P<0.01), and positive correlation between MSH6 and Survivin positive expression (r=0.435, P<0.01). Conclusions The positive expression rate of Survivin in colorectal cancer is high. MSH2, MSH6 and Survivin in colorectal cancer play an important role in the development and progression of colorectal cancer, and can provide evidence for the detection of these three factors, including metastasis risk, prognosis assessment and clinical treatment. In particular, Survivin gene may provide evidence for gene therapy. Key words: Colorectal neoplasms; MutS homolog 2 protein; MutS homolog 6 protein; Survivin
目的分析Survivin、MSH6、MSH2在结直肠癌组织中的表达变化,探讨其与临床病理参数的关系。方法应用免疫组化方法检测197例结直肠癌和20例炎性肠黏膜组织中Survivin、MSH6和MSH2的表达,分析Survivin、MSH6和MSH2表达的相关性。结果对照组20例炎性非肿瘤肠黏膜中MSH2、MSH6、Survivin的阳性表达率分别为95%、95%、10%。197例结直肠癌中MSH2、MSH6、Survivin的阳性表达率分别为88.3%、74.1%和84.3%。结直肠癌组Survivin阳性表达率显著高于炎症对照组(p0.05)。MSH2表达与肿瘤大小、淋巴结转移相关(p0.05)。MSH6表达与性别、淋巴结转移有关(p0.05)。结直肠癌组织中MSH6与MSH2呈正相关(r=0.326, P<0.01), MSH2与Survivin阳性表达呈正相关(r=0.277, P<0.01), MSH6与Survivin阳性表达呈正相关(r=0.435, P<0.01)。结论Survivin在结直肠癌中的阳性表达率较高。结直肠癌中MSH2、MSH6和Survivin在结直肠癌的发生发展中发挥重要作用,可为检测结直肠癌转移风险、评估预后及临床治疗提供依据。特别是Survivin基因可能为基因治疗提供证据。关键词:结直肠肿瘤;MutS同源蛋白2;MutS同源蛋白;生存素
{"title":"Expression and its clinicopathological significance of Survivin, MSH2 and MSH6 in colorectal cancer","authors":"Juhua Chen, Yili Wang, Hongwei H Zhang","doi":"10.3760/CMA.J.ISSN.1008-1372.2020.02.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2020.02.016","url":null,"abstract":"Objective \u0000To analyze the changes of Survivin, MSH6 and MSH2 expression in colorectal cancer and explore their relationship with clinical and pathological parameters. \u0000 \u0000 \u0000Methods \u0000197 cases of colorectal adenocarcinoma and 20 cases of inflammatory intestinal mucosa were detected by immunohistochemistry with Survivin, MSH6 and MSH2, and the correlation between Survivin, MSH6 and MSH2 expression was analyzed. \u0000 \u0000 \u0000Results \u0000In the control group of 20 cases with inflammatory non-tumor intestinal mucosa, the positive expression rate of MSH2, MSH6, Survivin were 95%, 95%, 10%, respectively. While the positive expression rate of MSH2, MSH6, Survivin were 88.3%, 74.1% and 84.3% in 197 cases of colorectal cancer. Survivin positive expression rate in colorectal cancer group was significantly higher than that in inflammatory control group (P 0.05). MSH2 expression was correlated with tumor size and lymph node metastasis (P 0.05). MSH6 expression was related to gender and lymph node metastasis (P 0.05). Colorectal cancer tissues showed positive correlation between MSH6 and MSH2 (r=0.326, P<0.01), positive correlation between MSH2 and Survivin positive expression (r=0.277, P<0.01), and positive correlation between MSH6 and Survivin positive expression (r=0.435, P<0.01). \u0000 \u0000 \u0000Conclusions \u0000The positive expression rate of Survivin in colorectal cancer is high. MSH2, MSH6 and Survivin in colorectal cancer play an important role in the development and progression of colorectal cancer, and can provide evidence for the detection of these three factors, including metastasis risk, prognosis assessment and clinical treatment. In particular, Survivin gene may provide evidence for gene therapy. \u0000 \u0000 \u0000Key words: \u0000Colorectal neoplasms; MutS homolog 2 protein; MutS homolog 6 protein; Survivin","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87805228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between urinary iodine and clinical characteristics in breast cancer 尿碘与乳腺癌临床特征的相关性
Q4 Medicine Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.ISSN.1008-1372.2020.02.008
Yupei Ren, Kun Wang, Yating Ma, Ka-te Huang, B. Yi
Objective To explore the relationship between urinary iodine level and breast cancer, we compare urinary iodine excretion levels in patients with breast cancer, benign breast disease, other female malignant tumors and control subjects in Xiangya Hospital of Central South University. Methods From December 2018 to January 2019, 64 patients with newly diagnosed breast cancer in Xiangya Hospital of Central South University were selected as case group, benign breast disease group (n=49), other female malignant tumor group (n=39) and health examination group (n=50) as control group. Urinary iodine was determined by colorimetry. According to the urinary iodine level the patients divided into three groups: iodine excess (>300 μg/L), medium iodine (100-300 μg/L) and iodine deficiency (<100 μg/L). The relationship between urinary iodine and clinicopathology of breast cancer was analyzed. Results The level of urinary iodine in benign breast nodule group 319.13(163.98)μg/L > breast cancer group 273.96(151.30)μg/L > female other malignant tumor group 212.95(161.71)μg/L > normal control group 199.15(194.45)μg/L, with significantly differance (H=9.936, P=0.019). Urinary iodine level in the normal control group was significantly lower than that in the benign breast disease group (P=0.013). The patients were further divided into three groups according to the urinary iodine level: iodine excess, iodine medium and iodine deficiency, the number of urine iodine <100 μg/L in the normal control group was significantly higher than that in the breast cancer group (P=0.021). The level of urinary iodine was negatively correlated with the size of the primary focus of breast cancer (Z=-2.307, P=0.021). The effect of urinary iodine was analyzed by multiple linear regression method. The size of primary focus was included in the regression equation (R2=0.136 , P=0.007), but had nothing to do with lymph node metastasis and the expression status of estrogen receptor (ER), androgen receptor (AR), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2). Conclusions There is a negative linear correlation between urinary iodine level and the size of primary focus of breast cancer, but it has nothing to do with lymph node metastasis and the expression of ER, AR, PR and HER-2. Key words: Breast neoplasms; Urinary iodine; Sodium iodine symporters
目的探讨尿碘水平与乳腺癌的关系,比较中南大学湘雅医院乳腺癌、乳腺良性疾病及其他女性恶性肿瘤患者与对照组的尿碘排泄水平。方法选择2018年12月至2019年1月中南大学湘雅医院新诊断乳腺癌患者64例作为病例组,乳腺良性疾病组(n=49),其他女性恶性肿瘤组(n=39),健康检查组(n=50)作为对照组。尿碘用比色法测定。根据尿碘水平将患者分为碘过量组(>300 μg/L)、中碘组(100-300 μg/L)和缺碘组(乳腺癌组273.96(151.30)μg/L >女性其他恶性肿瘤组212.95(161.71)μg/L >正常对照组199.15(194.45)μg/L,差异有统计学意义(H=9.936, P=0.019)。正常对照组尿碘水平显著低于乳腺良性病变组(P=0.013)。根据尿碘水平将患者进一步分为碘过量、碘中等和碘缺乏三组,正常对照组尿碘<100 μg/L的人数显著高于乳腺癌组(P=0.021)。尿碘水平与乳腺癌原发灶大小呈负相关(Z=-2.307, P=0.021)。采用多元线性回归法分析尿碘含量的影响。原发病灶的大小纳入回归方程(R2=0.136, P=0.007),但与淋巴结转移及雌激素受体(ER)、雄激素受体(AR)、孕激素受体(PR)、人表皮生长因子受体-2 (HER-2)的表达状况无关。结论尿碘水平与乳腺癌原发灶大小呈负线性相关,与淋巴结转移及ER、AR、PR、HER-2表达无关。关键词:乳腺肿瘤;尿碘;碘化钠
{"title":"Correlation between urinary iodine and clinical characteristics in breast cancer","authors":"Yupei Ren, Kun Wang, Yating Ma, Ka-te Huang, B. Yi","doi":"10.3760/CMA.J.ISSN.1008-1372.2020.02.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2020.02.008","url":null,"abstract":"Objective \u0000To explore the relationship between urinary iodine level and breast cancer, we compare urinary iodine excretion levels in patients with breast cancer, benign breast disease, other female malignant tumors and control subjects in Xiangya Hospital of Central South University. \u0000 \u0000 \u0000Methods \u0000From December 2018 to January 2019, 64 patients with newly diagnosed breast cancer in Xiangya Hospital of Central South University were selected as case group, benign breast disease group (n=49), other female malignant tumor group (n=39) and health examination group (n=50) as control group. Urinary iodine was determined by colorimetry. According to the urinary iodine level the patients divided into three groups: iodine excess (>300 μg/L), medium iodine (100-300 μg/L) and iodine deficiency (<100 μg/L). The relationship between urinary iodine and clinicopathology of breast cancer was analyzed. \u0000 \u0000 \u0000Results \u0000The level of urinary iodine in benign breast nodule group 319.13(163.98)μg/L > breast cancer group 273.96(151.30)μg/L > female other malignant tumor group 212.95(161.71)μg/L > normal control group 199.15(194.45)μg/L, with significantly differance (H=9.936, P=0.019). Urinary iodine level in the normal control group was significantly lower than that in the benign breast disease group (P=0.013). The patients were further divided into three groups according to the urinary iodine level: iodine excess, iodine medium and iodine deficiency, the number of urine iodine <100 μg/L in the normal control group was significantly higher than that in the breast cancer group (P=0.021). The level of urinary iodine was negatively correlated with the size of the primary focus of breast cancer (Z=-2.307, P=0.021). The effect of urinary iodine was analyzed by multiple linear regression method. The size of primary focus was included in the regression equation (R2=0.136 , P=0.007), but had nothing to do with lymph node metastasis and the expression status of estrogen receptor (ER), androgen receptor (AR), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2). \u0000 \u0000 \u0000Conclusions \u0000There is a negative linear correlation between urinary iodine level and the size of primary focus of breast cancer, but it has nothing to do with lymph node metastasis and the expression of ER, AR, PR and HER-2. \u0000 \u0000 \u0000Key words: \u0000Breast neoplasms; Urinary iodine; Sodium iodine symporters","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75766592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress on the relationship between inflammation and neuropathic pain 炎症与神经性疼痛关系的研究进展
Q4 Medicine Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.ISSN.1008-1372.2020.02.042
Long Yuan, Xuesong Li, Chunyang Meng, Hongmei Liu
Neuropathic pain (NP) is pain triggered or caused by primary damage and dysfunction of the nervous system. It belongs to a kind of chronic pain, which is manifested as spontaneous pain, hyperalgesia, abnormal pain, paresthesia and other clinical characteristics. Because the pathogenesis is not clear, the therapeutic effect is not satisfactory. After nerve injury, the glial cells in the injured site and dorsal root ganglia (DRG) release various inflammatory mediators to participate in the regulation of the transmission of damaging information. The inflammatory process of neuropathic pain may be accomplished through some signaling pathways. This article reviews the current research on the relationship between inflammation and neuropathic pain. Key words: Inflammation; Inflammatory mediators; Neuropathic pain; Signal transduction; Review
神经性疼痛(NP)是由神经系统的原发性损伤和功能障碍引发或引起的疼痛。它属于慢性疼痛的一种,表现为自发性疼痛、痛觉过敏、异常疼痛、感觉异常等临床特征。由于发病机制不明确,治疗效果不理想。神经损伤后,损伤部位的胶质细胞和背根神经节(DRG)释放多种炎症介质,参与调节损伤信息的传递。神经性疼痛的炎症过程可能通过一些信号通路来完成。本文就炎症与神经性疼痛关系的研究进展作一综述。关键词:炎症;炎症介质;神经性疼痛;信号转导;审查
{"title":"Research progress on the relationship between inflammation and neuropathic pain","authors":"Long Yuan, Xuesong Li, Chunyang Meng, Hongmei Liu","doi":"10.3760/CMA.J.ISSN.1008-1372.2020.02.042","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2020.02.042","url":null,"abstract":"Neuropathic pain (NP) is pain triggered or caused by primary damage and dysfunction of the nervous system. It belongs to a kind of chronic pain, which is manifested as spontaneous pain, hyperalgesia, abnormal pain, paresthesia and other clinical characteristics. Because the pathogenesis is not clear, the therapeutic effect is not satisfactory. After nerve injury, the glial cells in the injured site and dorsal root ganglia (DRG) release various inflammatory mediators to participate in the regulation of the transmission of damaging information. The inflammatory process of neuropathic pain may be accomplished through some signaling pathways. This article reviews the current research on the relationship between inflammation and neuropathic pain. \u0000 \u0000Key words: \u0000Inflammation; Inflammatory mediators; Neuropathic pain; Signal transduction; Review","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75562553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic review on the curative effect of total hip arthroplasty through direct anterior approach versus posterolateral Approach 全髋关节置换术直接前路与后外侧入路疗效的系统评价
Q4 Medicine Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.ISSN.1008-1372.2020.02.009
Heng Li, W. Weng, Hong-hang Yang, Zhenguo Sun
Objective To systematic evaluate the curative effect of total hip arthroplasty (THA) through direct anterior approach versus (DAA) posterolateral approach (PSA). Methods All the randomized controlled trial (RCT) articles and observational research articles about the curative effect of THA through direct anterior approach (DAA group) versus posterolateral approach (PSA group)for treatment of hip disease that published at home and abroad included from database establishing to December 2017 were retrieved from Cochrane Library, Pubmed, Web of Science, CBM and China national knowledge internet (CNKI) through computer. The articles were screened and the information was extracted independently by two authors. A Meta-analysis was performed utilizing the RevMan 5.3 software. Results Two hundred and forty-nine articles were searched out in the initial stage. After screening, 7 Chinese articles and 2 English articles (942 cases)were included in the final analysis, including 8 RCT articles and 1 observational research article, and 463 patients in direct anterior approach and 479 patients in posterolateral approach. The results of Meta-analysis demonstrated that the incision length, operation time, intraoperative blood less, Harris hip function scores at 1 month after surgery, visual analogue scale (VAS) scores at 24 hours after surgery, postoperative bed rest time and the hospital stay were better in DAA group compared to PSA group (SMD=-2.51, 95% CI: -4.84, -0.19, P=0.03); (SMD=0.84, 95% CI: 0.10, 1.59, P=0.03); (SMD=-1.52, 95% CI: -2.98, -0.05, P=0.04); (SMD=2.58, 95% CI: 0.65, 4.51, P=0.009); (SMD=-0.65, 95% CI: -0.91, -0.38, P<0.01); (SMD=-1.85, 95% CI: -3.00, -0.70, P=0.002); (SMD=-1.12, 95% CI: -1.62, -0.61, P<0.01). There were no statistical difference in drainage (SMD=-1.45, 95% CI: -3.40, 0.49, P=0.14), Harris hip function scores at last follow-up (SMD=0.91, 95% CI: -0.31, 2.14, P=0.15), VAS scores at 48 hours after surgery (SMD=-1.21, 95% CI: -3.03, 0.61, P=0.19), acetabular anteversion angles (SMD=-0.50, 95% CI: -1.06, 0.05, P=0.07), acetabular abduction angles (SMD=-0.01, 95% CI: -0.32, 0.30, P=0.97) and incidence of complications (OR=1.10, 95% CI: 0.59, 2.07, P=0.77) between the 2 groups. The result of analysis of publication bias according to Harris hip function scores at last follow-up and incidence of complications showed that the funnel-plot was essentially bilateral symmetry. Conclusions THA through DAA can significantly reduce the soft-tissue damage, and it is beneficial for patient's quick recovery, also it conforms to the current concept of minimally invasive treatment that worthy of promotion. Key words: Arthroplasty, replacement, hip; Meta-analysis
目的系统评价全髋关节置换术(THA)直接前路入路与后外侧入路(PSA)的疗效。方法从Cochrane Library、Pubmed、Web of Science、CBM、中国知网(CNKI)等数据库中,通过计算机检索建立数据库至2017年12月为止国内外发表的关于THA经直接前路入路(DAA组)与后外侧入路(PSA组)治疗髋关节病疗效的随机对照试验(RCT)和观察性研究文章。文章经过筛选,信息由两位作者独立提取。采用RevMan 5.3软件进行meta分析。结果初步检索到文献249篇。经筛选,最终纳入中文文献7篇,英文文献2篇(942例),其中RCT文献8篇,观察性研究文献1篇,直接前路入路463例,后外侧入路479例。meta分析结果显示,DAA组在切口长度、手术时间、术中出血量、术后1个月Harris髋关节功能评分、术后24小时VAS评分、术后卧床休息时间、住院时间等方面均优于PSA组(SMD=-2.51, 95% CI: -4.84, -0.19, P=0.03);(smd =0.84, 95% ci: 0.10, 1.59, p =0.03);(smd =-1.52, 95% ci: -2.98, -0.05, p =0.04);(smd =2.58, 95% ci: 0.65, 4.51, p =0.009);(smd =-0.65, 95% ci: -0.91, -0.38, p <0.01);(smd =-1.85, 95% ci: -3.00, -0.70, p =0.002);(smd =-1.12, 95% ci: -1.62, -0.61, p <0.01)。两组患者在引流(SMD=-1.45, 95% CI: -3.40, 0.49, P=0.14)、末次随访Harris髋关节功能评分(SMD=0.91, 95% CI: -0.31, 2.14, P=0.15)、术后48 h VAS评分(SMD=-1.21, 95% CI: -3.03, 0.61, P=0.19)、髋臼前倾角(SMD=-0.50, 95% CI: -1.06, 0.05, P=0.07)、髋臼外倾角(SMD=-0.01, 95% CI: -0.32, 0.30, P=0.97)、并发症发生率(OR=1.10, 95% CI: 0.59, 2.07, P=0.77)方面均无统计学差异。根据Harris髋关节功能评分和并发症发生率进行发表偏倚分析结果显示,漏斗图基本为双侧对称。结论经DAA THA可明显减轻软组织损伤,有利于患者快速康复,符合当前微创治疗理念,值得推广。关键词:髋关节置换术;荟萃分析
{"title":"Systematic review on the curative effect of total hip arthroplasty through direct anterior approach versus posterolateral Approach","authors":"Heng Li, W. Weng, Hong-hang Yang, Zhenguo Sun","doi":"10.3760/CMA.J.ISSN.1008-1372.2020.02.009","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2020.02.009","url":null,"abstract":"Objective \u0000To systematic evaluate the curative effect of total hip arthroplasty (THA) through direct anterior approach versus (DAA) posterolateral approach (PSA). \u0000 \u0000 \u0000Methods \u0000All the randomized controlled trial (RCT) articles and observational research articles about the curative effect of THA through direct anterior approach (DAA group) versus posterolateral approach (PSA group)for treatment of hip disease that published at home and abroad included from database establishing to December 2017 were retrieved from Cochrane Library, Pubmed, Web of Science, CBM and China national knowledge internet (CNKI) through computer. The articles were screened and the information was extracted independently by two authors. A Meta-analysis was performed utilizing the RevMan 5.3 software. \u0000 \u0000 \u0000Results \u0000Two hundred and forty-nine articles were searched out in the initial stage. After screening, 7 Chinese articles and 2 English articles (942 cases)were included in the final analysis, including 8 RCT articles and 1 observational research article, and 463 patients in direct anterior approach and 479 patients in posterolateral approach. The results of Meta-analysis demonstrated that the incision length, operation time, intraoperative blood less, Harris hip function scores at 1 month after surgery, visual analogue scale (VAS) scores at 24 hours after surgery, postoperative bed rest time and the hospital stay were better in DAA group compared to PSA group (SMD=-2.51, 95% CI: -4.84, -0.19, P=0.03); (SMD=0.84, 95% CI: 0.10, 1.59, P=0.03); (SMD=-1.52, 95% CI: -2.98, -0.05, P=0.04); (SMD=2.58, 95% CI: 0.65, 4.51, P=0.009); (SMD=-0.65, 95% CI: -0.91, -0.38, P<0.01); (SMD=-1.85, 95% CI: -3.00, -0.70, P=0.002); (SMD=-1.12, 95% CI: -1.62, -0.61, P<0.01). There were no statistical difference in drainage (SMD=-1.45, 95% CI: -3.40, 0.49, P=0.14), Harris hip function scores at last follow-up (SMD=0.91, 95% CI: -0.31, 2.14, P=0.15), VAS scores at 48 hours after surgery (SMD=-1.21, 95% CI: -3.03, 0.61, P=0.19), acetabular anteversion angles (SMD=-0.50, 95% CI: -1.06, 0.05, P=0.07), acetabular abduction angles (SMD=-0.01, 95% CI: -0.32, 0.30, P=0.97) and incidence of complications (OR=1.10, 95% CI: 0.59, 2.07, P=0.77) between the 2 groups. The result of analysis of publication bias according to Harris hip function scores at last follow-up and incidence of complications showed that the funnel-plot was essentially bilateral symmetry. \u0000 \u0000 \u0000Conclusions \u0000THA through DAA can significantly reduce the soft-tissue damage, and it is beneficial for patient's quick recovery, also it conforms to the current concept of minimally invasive treatment that worthy of promotion. \u0000 \u0000 \u0000Key words: \u0000Arthroplasty, replacement, hip; Meta-analysis","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82378849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention and treatment strategies of Traditional Chinese and Western Medicine for acute abdomen during the outbreak of COVID-19/ 中国医师杂志 新型冠状病毒病疫情期间急腹症的中西医防治策略
Q4 Medicine Pub Date : 2020-02-27 DOI: 10.3760/CMA.J.CN431274-20200221-00168
Guolei Li, Guoliang Tan, Yuan-hua Liu, Zhu Xu, H. Feng, Yali Zhang, Wei-Hong Xing, Zhi-feng Xu
At present, the prevention and control of the COVID-19 is still severe, its pathogen SARS-CoV-2 is highly infectious and pathogenic, and the population is generally susceptible. In order to deal with the epidemic, selective operation can be postponed, but most of the patients with acute abdominal diseases are commonly in clinic, with acute onset and severe condition, and most of them are accompanied with fever and gastrointestinal symptoms, so emergency operation is needed.Under the condition of the current epidemic—COVID-19, it requires a higher standard to diagnose and treat patients with acute abdomen. The first step is to carry out procedures to identify whether the patient is infected or not. Those who are not infected can go through the normal treating procedures.For patients diagnosed with COVID-19 or suspected patients, the second step is to achieve classified diagnoses and treatments, and to adopt a treating plan that integrates TCM and western medicine.In order to protect patients and medical staff, the COVID-19 in hospital transmission must be avoided. For patients with COVID-19 who need emergency surgery, we must strictly comply with the hospital's protection regulations, closely coordinate the relevant departments of surgery, perform the three-level protection, operate in accordance with the principle of damage control in the negative pressure surgery room, and return to the isolation ward according to the prevention and control process after operation. For units without surgical conditions, patients should be transferred to hospital in time on the premise of maximum damage control, and patients must not be delayed for timely diagnosis and treatment due to the epidemic. Key words: novel coronavirus; pneumonia; viral; acute abdominal diseases; Traditional Chinese and Western Medicine
当前,新冠肺炎防控形势依然严峻,其病原SARS-CoV-2具有高传染性和致病性,人群普遍易感。为应对疫情,可推迟选择性手术,但急腹症患者多为临床常见病,起病急,病情严重,且多伴有发热及胃肠道症状,需急诊手术。在当前新冠肺炎疫情的情况下,对急腹症患者的诊治提出了更高的标准。第一步是执行程序来确定病人是否被感染。未感染者可按正常程序进行治疗。对于确诊的新冠肺炎患者或疑似患者,第二步是实现分类诊疗,采用中西医结合的治疗方案。为了保护患者和医护人员,必须避免院内传播。对需要急诊手术的新冠肺炎患者,必须严格遵守医院防护规定,密切配合手术相关科室,做好三级防护,在负压手术室按照损害控制原则操作,术后按照防控流程返回隔离病房。对于没有手术条件的单位,应在最大限度控制损害的前提下,及时将患者转送医院,不得因疫情耽误患者及时诊治。关键词:新型冠状病毒;肺炎;病毒;急性腹部疾病;中西医结合
{"title":"Prevention and treatment strategies of Traditional Chinese and Western Medicine for acute abdomen during the outbreak of COVID-19/ 中国医师杂志","authors":"Guolei Li, Guoliang Tan, Yuan-hua Liu, Zhu Xu, H. Feng, Yali Zhang, Wei-Hong Xing, Zhi-feng Xu","doi":"10.3760/CMA.J.CN431274-20200221-00168","DOIUrl":"https://doi.org/10.3760/CMA.J.CN431274-20200221-00168","url":null,"abstract":"At present, the prevention and control of the COVID-19 is still severe, its pathogen SARS-CoV-2 is highly infectious and pathogenic, and the population is generally susceptible. In order to deal with the epidemic, selective operation can be postponed, but most of the patients with acute abdominal diseases are commonly in clinic, with acute onset and severe condition, and most of them are accompanied with fever and gastrointestinal symptoms, so emergency operation is needed.Under the condition of the current epidemic—COVID-19, it requires a higher standard to diagnose and treat patients with acute abdomen. The first step is to carry out procedures to identify whether the patient is infected or not. Those who are not infected can go through the normal treating procedures.For patients diagnosed with COVID-19 or suspected patients, the second step is to achieve classified diagnoses and treatments, and to adopt a treating plan that integrates TCM and western medicine.In order to protect patients and medical staff, the COVID-19 in hospital transmission must be avoided. For patients with COVID-19 who need emergency surgery, we must strictly comply with the hospital's protection regulations, closely coordinate the relevant departments of surgery, perform the three-level protection, operate in accordance with the principle of damage control in the negative pressure surgery room, and return to the isolation ward according to the prevention and control process after operation. For units without surgical conditions, patients should be transferred to hospital in time on the premise of maximum damage control, and patients must not be delayed for timely diagnosis and treatment due to the epidemic. \u0000 \u0000Key words: \u0000novel coronavirus; pneumonia; viral; acute abdominal diseases; Traditional Chinese and Western Medicine","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90544512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国医师杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1